WO2021011885A1 - Claudin18 antibodies and methods of treating cancer - Google Patents

International application published with international search report

WO2019174617A1 - Anti-claudin 18.2 antibodies - Google Patents

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

WO2022063272A1 - Novel anti-claudin18 antibodies - Google Patents

WO2021011885A1 - Claudin18 antibodies and methods of treating cancer - Google Patents

WO2021088927A1 - Antibody-drug conjugates targeting claudin 18.2 - Google Patents

WO2021011885A1 - Claudin18 antibodies and methods of treating cancer - Google Patents

Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells

WO2022063272A1 - Novel anti-claudin18 antibodies - Google Patents

WO2021198157A1 - Rna compositions targeting claudin-18.2 - Google Patents

WO2021025177A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

WO2020025792A1 - Antibody constructs for cldn18.2 and cd3 - Google Patents

WO2021024020A1 - Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer - Google Patents

Recombinant Anti-Claudin18.2 antibody [EPR19202] (ab222512)

US20220041712A1 - Anti-claudin 18 antibodies and methods of use thereof - Google Patents